Friday 01 February 2008 - CHILTERN ANNOUNCED TODAY THAT IT HAS ACQUIRED THE BUSINESS OF DRUG DEVELOPMENT SOLUTIONS (DDS)

Chiltern, the global contract research organization, announced today that it has acquired the business of Drug Development Solutions (DDS), a leading Phase 1 unit located at Ninewells Hospital and Medical School, Dundee, Scotland. Ninewells is one of the United Kingdom’s major teaching hospitals. The purchase of DDS supplements Chiltern’s Clinical Research Unit in Slough near London.

To read more, please click here

--------------------------------------------------------------------------------------